What We Know About Ketamine

What We Know About
Ketamine For Depression

Tiago Gil, MD


February 24, 2022

First of all: Ketamine has antidepressant activity.

 How we know about it ketamine’s antidepressant properties? Well, a lot of studies have been done since the J. Krystal first paper1 and the accumulated evidence summarized by Cochrane for unipolar type of disease2, showed us that ketamine is 15.84 times better in treating depression than placebo at 72 hours.

That´s the main picture, now let´s look at the details. 

The American Society of Ketamine Physicians, Psychotherapists & Practitioners presents:

What We Know About Ketamine

Presenters:  TIAGO GIL, MD


When:  February 24, 2022 4:00 PM PST / 7:00 PM EST

Membership Webinar


Upcoming Topics

Past Months

          • March – Bipolar
          • April – Treatment Resistant Depression
          • May – Ketamine & TMS
          • June – Standards & Ethics
          • July – Psychiatry: When to refer a patient 
          • August – PTSD/Veterans
          • September – Suicidality and Crisis
          • October – Legal
          • November – Eating Disorders & Addiction
          • December – Pain

Disclaimer: The information provided by ASKP3 (“we,” “us” or “our”) on ASKP.org (the “Site”) is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site. Under no circumstance shall we have any liability to you for any loss or damage of any kind incurred as a result of the use of the site or reliance on any information provided on the site. Your use of the site and your reliance on any information on the site is solely at your own risk.